Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Fatigue | Phase 2 | ClinicalTrials |
| Disease; Fatigue; Leukemia; Lymphoma; Lymphoproliferative Disorders; Multiple Myeloma; Myelodysplastic-Myeloproliferative Diseases; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; Neoplasms, Plasma Cell; Precancerous Conditions; Preleukemia; Syndrome | Phase 3 | ClinicalTrials |
| Breast Neoplasms; Colonic Neoplasms; Fatigue | Early Phase 1 | ClinicalTrials |
CONTENTS